Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Effects of Communicating Genetic Risk of Type 2 Diabetes and Wearable Technologies On Objectively Measured Behavioral Outcomes in Overweight or Obese East Asian Individuals.

NCT05524909 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT05524909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05524909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Effects of Communicating Genetic Risk of Type 2 Diabetes and Wearable Technologies On Objectively Measured Behavioral Outcomes in Overweight or Obese East Asian Individuals.
Lead sponsor
The University of Hong Kong
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2022
Completion date
June 30, 2025
Enrollment
355 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

exercise, fitness trackers, genetic predisposition to disease, physical activity, type 2 diabetes